(Reuters) - U.S. inspectors are still uncovering a host of problems at a Johnson & Johnson manufacturing plant that was the source of a major recall of dozens of popular children's medications earlier this year. In an inspection report released late on Wednesday, the Food and Drug Administration said a recent visit uncovered multiple quality control problems, including a failure to properly handle customer complaints.
